LINCOLNSHIRE, Ill., April 06, 2026--(BUSINESS WIRE)--Nexus Pharmaceuticals, LLC announces the launch of Cyclophosphamide Injection, available in ready to dilute 2.5 mL fill and 5 mL fill multiple-dose ...

To determine the maximum-tolerated dose, toxicity, pharmacokinetics, and biologic effects of G3139 when administered with doxorubicin and cyclophosphamide to children with relapsed solid tumors.

Please provide your email address to receive an email when new articles are posted on . Results showed two regimens — 120 mg/kg cyclophosphamide and 125 mg/m 2 fludarabine, or 60 mg/kg ...

Humoral tumor-associated immune responses induced by catumaxomab in patients with malignant ascites. A phase I clinical trial of a genetically modified and imageable oncolytic vaccinia virus GL-ONC1 ...

Cyclophosphamide mg Powder for Solution for Injection or Infusion 2. Cytokines, tiny proteins, are messengers of intercellular inflammation, immune response, and tissue repair or remodeling. Drug Type ...

BRIDGEWATER, N.J., May 30, 2018 /PRNewswire/ -- Amneal Pharmaceuticals, Inc.(NYSE: AMRX), a specialty pharmaceutical company, today announced it has received U.S. Food and Drug Administration (FDA) ...

Bulletin: ...FROST ADVISORY IN EFFECT FROM 2 AM TO 8 AM EDT SUNDAY... * WHAT...Temperatures as low as 36 will result in frost formation. * WHERE...Berks, Western ...